A new Cochrane Library editorial has been published following the publication of a Cochrane review by Yotsu and colleagues which summarises the evidence of drug treatments for treating Buruli ulcer.The Cochrane Review describes the past decades of Buruli ulcer clinical chemotherapy research. It provides an important clinical research agenda, and it helps clinicians to share current evidence with their patients for shared decision‐making. These studies represent the long and winding road from surgical to predominantly antimicrobial treatment. Maintaining high standards of clinical trial design, including auditing and monitoring, is a moral imperative that should not be undermined by shortcomings in resources directed to neglected tropical diseases such as Buruli ulcer.
Find the Editorial here: Treatment for Buruli ulcer: the long and winding road to antimicrobials-first
The CIDG editorial base is located at the Liverpool School of Tropical Medicine in Liverpool, UK. The CIDG is led by Professor Paul Garner (Co-ordinating Editor) and Deirdre Walshe (Managing Editor). Over 600 authors from some 52 countries contribute to the preparation of the Cochrane Reviews. They are supported by an international team of Editors, each with topic or methodological expertise.
The CIDG’s main areas of work are on determination of the effects of interventions on the prevention or treatment infectious diseases of relevance to the United Nations Sustainable Development Goals, particularly malaria, tuberculosis, HIV/AIDS, and neglected tropical diseases. The aims of the CIDG are to impact on policy and research in tropical diseases through the production of high quality and relevant systematic reviews, and to lead developments in review quality improvement and effective dissemination of findings.